Appropriate composites of cefoperazone-sulbactam against multidrug-resistant organisms

about

Appropriate composites of cefoperazone-sulbactam against multidrug-resistant organisms

Item

http://www.wikidata.org/entity/Q58751109

description

im Jahr 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Appropriate composites of cefoperazone-sulbactam against multidrug-resistant organisms

@en

Appropriate composites of cefoperazone-sulbactam against multidrug-resistant organisms

@nl

type

Item

label

Appropriate composites of cefoperazone-sulbactam against multidrug-resistant organisms

@en

Appropriate composites of cefoperazone-sulbactam against multidrug-resistant organisms

@nl

prefLabel

Appropriate composites of cefoperazone-sulbactam against multidrug-resistant organisms

@en

Appropriate composites of cefoperazone-sulbactam against multidrug-resistant organisms

@nl

P1476

Appropriate composites of cefoperazone-sulbactam against multidrug-resistant organisms

@en

P2093

Chi-Chung Chen

http://www.w3.org/2001/XMLSchema#string

Chih-Cheng Lai

http://www.w3.org/2001/XMLSchema#string

Hung-Jen Tang

http://www.w3.org/2001/XMLSchema#string

Tsuey-Pin Lin

http://www.w3.org/2001/XMLSchema#string

Ying-Chen Lu

http://www.w3.org/2001/XMLSchema#string

P2860

Three decades of beta-lactamase inhibitors

In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan: SMART 2004 programme data.

In vitro activities of cefoperazone and sulbactam singly and in combination against cefoperazone-resistant members of the family Enterobacteriaceae and nonfermenters.

The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril!

Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations

The role of doxycycline in the therapy of multidrug-resistant E. coli - an in vitro study.

Novel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy.

Synergistic effects of sulbactam in multi-drug-resistant Acinetobacter baumannii.

beta-Lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone.

Comparison of four beta-lactamase inhibitors in combination with ampicillin against Mycobacterium tuberculosis.

P304

1441-1445

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IDR.S175257

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Chuang Yin-ching

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30237728

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

infectious disease

multiple drug resistance

P932

6138961

http://www.w3.org/2001/XMLSchema#string